Vanda Pharmaceuticals, Inc. v. FDA
D.C. Circuit Vacates FDA's Rejection of Vanda's Hetlioz sNDA
cadc · 2025-08-15 · Mixed · Impact: 65/100
Vanda Pharmaceuticals, Inc. v. FDA, decided by D.C. Circuit on August 15, 2025, resulted in a mixed outcome. The D.C. Circuit reviewed the FDA's refusal to approve Vanda Pharmaceuticals' supplemental ...